Theravance Biopharma, Inc. · NASDAQ:TBPH
Farnum Rhonda sold 13,314 Theravance Biopharma, Inc. shares (Form 4)
Traded Jun 15, 2026 · Filed Jun 17, 2026
On Jun 15, 2026, Farnum Rhonda (SVP, COMM & MEDICAL AFFAIRS) sold 13,314 Theravance Biopharma, Inc. shares at an average US$16.39 for US$218K under a trading plan, leaving 232,457 shares. Filed Jun 17, 2026 (Form 4).
- Sold
- 13,314 shares
- Price
- US$16.39 average (US$16.38 to US$16.39)
- Value
- US$218K
- Holding after
- 232,457 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- SVP, COMM & MEDICAL AFFAIRS
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 15, 2026 | Ordinary Shares | Sale | 3,329 | US$16.39 | 242,442 | Direct |
| Jun 15, 2026 | Ordinary Shares | Sale | 3,328 | US$16.38 | 239,114 | Direct |
| Jun 15, 2026 | Ordinary Shares | Sale | 6,657 | US$16.39 | 232,457 | Direct |
Source
Related
- Theravance Biopharma, Inc.
- Farnum Rhonda
- Theravance Biopharma, Inc. shareholders
- Form 4 · Farnum Rhonda · Sep 24, 2026
- Form 4 · Farnum Rhonda · Sep 17, 2026
- Form 4 · Farnum Rhonda · Aug 24, 2026
- Form 4 · Farnum Rhonda · May 22, 2026
- Form 4 · Farnum Rhonda · Apr 3, 2026
- Form 4 · Weiss Asset Management LP · Sep 28, 2026
- Schedule 13D/A · Weiss Asset Management LP · Sep 25, 2026
- Form 4 · Pakianathan Deepika · Sep 24, 2026
- Form 4 · O'Connor Donal · Sep 24, 2026
- Form 4 · Mitchell Dean J · Sep 24, 2026